China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2008 | |
| Cash Flows From Operating Activities | |
| Net Income | 2,260 |
| Depreciation Amortization | 300 |
| Other Working Capital | -1,150 |
| Other Operating Activity | 600 |
| Operating Cash Flow | $2,010 |
| Cash Flows From Investing Activities | |
| PPE Investments | -1,350 |
| Other Investing Activity | -10 |
| Investing Cash Flow | $-1,360 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | -690 |
| Financing Cash Flow | $-690 |
| Exchange Rate Effect | 180 |
| Beginning Cash Position | 5,010 |
| End Cash Position | 5,150 |
| Net Cash Flow | $140 |
| Free Cash Flow | |
| Operating Cash Flow | 2,010 |
| Free Cash Flow | 2,010 |